Literature DB >> 16681236

Streptococcus intermedius: an unusual cause of a primary empyema.

Said B Iskandar1, Muhanad A Al Hasan, Thomas M Roy, Ryland P Byrd.   

Abstract

Despite the evolution of modern antibiotics, pleural space infection remains a common illness with significant morbidity and mortality. Every year up to 60 percent of the 1.2 million patients in the United States who present with community-acquired pneumonia develop parapneumonic pleural effusions. Few of these parapneumonic effusions progress to an empyema. Interestingly, in about 10 percent of the cases of empyema, no underlying pulmonary infection can be identified. These pleural space infections are called primary empyemas. We present a patient with a primary empyema caused by Streptococcus intermedius. Relatively few studies have investigated primary empyema caused Streptococcus intermedius. This case presentation serves as a reminder to the clinician about primary empyema caused by this micro-organism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16681236

Source DB:  PubMed          Journal:  Tenn Med        ISSN: 1088-6222


  4 in total

1.  Streptococcus intermedius Causing Necrotizing Pneumonia in an Immune Competent Female: A Case Report and Literature Review.

Authors:  Faris Hannoodi; Israa Ali; Hussam Sabbagh; Sarwan Kumar
Journal:  Case Rep Pulmonol       Date:  2016-11-06

2.  Clinical and microbiologic characteristics of pleuro-pulmonary infection due to Streptococcus intermedius.

Authors:  F Cobo; A Sampedro; J Rodríguez-Granger; L Aliaga-Martínez; J M Navarro-Marí
Journal:  Rev Esp Quimioter       Date:  2018-03-22       Impact factor: 1.553

3.  An isolated pulmonary nodule secondary to Streptococcus intermedius infection in an otherwise healthy 10-year-old boy: A case report and literature review.

Authors:  Meixia Huang; Shuxian Li; Xiling Wu; Dan Xu; Lanfang Tang; Zhimin Chen
Journal:  Front Pediatr       Date:  2022-09-07       Impact factor: 3.569

4.  A false-positive pneumococcal rapid urinary antigen test in Streptococcus intermedius infection.

Authors:  Saeko Takahashi; Takahiro Ishitsuka; Kaoru Namatame; Morio Nakamura
Journal:  Respirol Case Rep       Date:  2019-08-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.